Topic:

R&D

Latest Headlines

Latest Headlines

Combining light-activated and chemical treatments, new nanoparticles are more effective against tumors

A team of researchers in Massachusetts is developing a two-in-one nanoparticle that delivers both a photodynamic therapy and a molecular therapy to treat highly resistant tumors--such as those associated with pancreatic cancer--with decreased toxicity.

UNC team delivers cancer drugs wrapped in exosomes to cut doses

Researchers at the University of North Carolina have developed a method of drug delivery using exosomes to protect cancer drugs in the body before they reach their target, effectively cutting the necessary dose.

Galapagos' bowel drug misses the mark in Phase II

Belgian biotech Galapagos is shutting down an ulcerative colitis program after its top prospect failed to make a difference in a Phase II trial, putting off plans for late-stage development as the company weighs whether to move forward in another disease.

Startup Co-D aims to resuscitate failed BMS drug using polymeric micelle drug delivery

University of Wisconsin-Madison spinout Co-D is deploying its polymeric micelle drug delivery platform with the aim of commercializing a failed Bristol-Myers Squibb cancer drug. So-called Triolimus boasts FDA's orphan drug designation to treat the rare blood vessel cancer angiosarcoma, a milestone that will accelerate its path to FDA approval (or rejection).

Zika outbreak triggers R&D attention from pharma, governments

As the Zika virus continues to grab headlines and its spread threatens, governments and industry are urgently committing resources and analyzing vaccine development options.

Panasonic, Kyoto University unveil radar-based remote vital sign sensor

Kyoto University and Panasonic have revealed a novel vital-sign-sensing technology that's based on radar. This enables the system to remotely detect heart rate and heartbeat interval without any sensors being placed on the patient's body. The accuracy of the system is on par with electrocardiographs.

Cedars-Sinai to test Fitbit activity trackers in cancer clinical trial

Cedars-Sinai is planning to trial the use of Fitbit Charge HR activity trackers to gauge the suitability of cancer patients for certain treatments, MobiHealthNews reports.

Bureaucracy holds up made-in-India heart valves

Prime Minister Narendra Modi has been trying to attract foreign investment with his "Make in India" campaign, but the reality at home was thrown into sharp relief with the news recently that a project to make heart valves in an Indian special economic zone was being stymied because of "pending approvals, delayed clearances and lack of financing options," according to a report by the Economic Times.

Ceva enters pact with Zoion to develop treatment for dry eye in dogs

Eye diseases have become so prevalent in pets that the number of veterinarians certified in ophthalmology has jumped 33% in the past 5 years to more than 400 in the U.S. alone, according to the American Veterinary Medical Association. Now several animal health companies are answering the call for new products to treat eye diseases, among them France's Ceva Santé Animale.

CRISPR biotech Intellia leases a big R&D hub in Cambridge, MA

Intellia Therapeutics, a Novartis-backed biotech working on gene-editing technology, leased a sizable research space in the hotbed of Cambridge, MA.
'